On multivariate analysis, the gender, age, TNM stage, tumor location PD-L1 expression, and the number of lines of previous systemic therapies were not indicative of progression-free survival and overall survival, and previous radiotherapy within 3 months was significantly related to longer PFS and OS (p < 0.05) (Table 2). This evidence concerns the gene CD274 and neoplasm.